Compositions and methods for enhancing virus efficacy

US8940291B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8940291-B2
Application numberUS-201013382355-A
CountryUS
Kind codeB2
Filing dateJul 7, 2010
Priority dateJul 7, 2009
Publication dateJan 27, 2015
Grant dateJan 27, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are viral sensitizing compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the cytotoxicity of virus to cells. Other uses, compositions and methods of using same are also provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of enhancing the production of a virus in cells comprising: producing a composition comprising the virus and a viral sensitizing agent by administering the viral sensitizing agent to said cells prior to, after, or concurrently with the virus; and culturing the virus and cells to enhance the production of the virus in said cells; wherein the viral sensitizing agent is of the formula:…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8940291B2 cover?
Provided are viral sensitizing compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the cytotoxicity of virus to cells. Other uses, compositions and methods of using same are also provided.
Who is the assignee on this patent?
Bell John, Diallo Jean-Simon, Le Boeuf Fabrice, and 1 more
What technology area does this patent fall under?
Primary CPC classification A61K31/341. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).